{"title":"Test Kit","description":"","products":[{"product_id":"intestinal-permeability-assessment-ipa-g","title":"Intestinal Permeability Assessment (IPA-G) X 1 Test Kit","description":"\u003cp\u003eDescription--\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigestive symptoms:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eOngoing bloating, abdominal discomfort or altered bowel habits.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFood reactions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eSuspected food sensitivities or food-related digestive responses.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInflammatory conditions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eConditions associated with gastrointestinal inflammation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAutoimmune conditions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAutoimmune disorders with a suspected gut involvement.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkin conditions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eChronic skin concerns that may be associated with gut health.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFatigue patterns:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ePersistent or unexplained fatigue.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePost-infection changes:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eDigestive symptoms following gastrointestinal infection or illness.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMedication history:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eLong-term use of medications known to affect gut integrity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eComplex presentations:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eMulti-system symptoms where gut barrier function is being explored.\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003eLabel--\u003c\/p\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv class=\"tab-pane active\" id=\"tab_2\"\u003e\n\u003cp\u003eThe Intestinal Permeability Assessment (IPA - G) is a urine-based test that measures the percentage recovery of lactulose and mannitol following oral ingestion. The test assesses urinary recovery values and the lactulose-to-mannitol ratio using enzymatic methodology, providing quantitative markers related to intestinal permeability.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThis test may be clinically useful when practitioners are exploring how substances pass through the intestinal lining. Comparing the recovery of two differently sized sugars offers insight into permeability patterns that may relate to digestive symptoms, food reactions or inflammatory presentations.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003ePractitioners typically interpret IPA results alongside clinical history, dietary intake, medication use and other relevant laboratory findings. Results are considered in context, including renal function and timing of sample collection, when reviewing findings with clients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cspan id=\"ctl00_cphBody_lblServingdetails\"\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 0.875rem;\"\u003eDosage--\u003c\/span\u003e\u003cstrong style=\"font-size: 0.875rem;\"\u003e\u003c\/strong\u003e\u003ca rel=\"noopener\" href=\"https:\/\/dnalifevms.com\/ProductPDF\/IntestinalPermeability-NordicSample-Reportpdf_2537.pdf\" target=\"_blank\"\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003cp\u003eResearch--\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e","brand":"Nordic Laboratories","offers":[{"title":"Default Title","offer_id":47992758894747,"sku":"TK-IPA-G","price":21755.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/TK-IPA-G.webp?v=1781283508"},{"product_id":"metabolomix-x-1-test-kit","title":"Metabolomix+ x 1 Test Kit","description":"\u003cp\u003eDescription--\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eFatigue or low energy:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eTiredness or reduced stamina that may relate to mitochondrial dysfunction or nutrient insufficiency.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMood and cognitive health:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eLow mood, anxiety, poor focus or memory changes possibly linked to neurotransmitter or amino acid metabolism.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic stress:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eOngoing stress or poor stress resilience that may influence adrenal function, energy production or nutrient demand.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eInflammation and oxidative stress:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eJoint discomfort, tissue irritation or signs of oxidative imbalance that may reflect antioxidant depletion.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigestive function:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eBloating, altered bowel habits or signs of malabsorption that may be associated with dysbiosis or nutrient absorption issues.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiometabolic health:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eWeight gain, blood sugar imbalance or early cardiovascular changes potentially linked to fatty acid or organic acid markers.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNutrient status:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eAssessment of functional need for antioxidants, B-vitamins, amino acids and minerals that support metabolic pathways.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic function:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eExploration of altered organic acid, amino acid or fatty acid patterns in complex presentations affecting energy, cognition or weight regulation.\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLabel--\u003c\/p\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv id=\"tab_2\" class=\"tab-pane active\"\u003e\n\u003cp\u003eMetabolomix+ combines several nutritional profiles to provide a broad analysis of key organic acids, amino acids and oxidative stress markers. This integrated approach evaluates core biochemical pathways and offers a functional overview of nutrient status, energy metabolism and detoxification capacity, helping to identify potential nutritional insufficiencies or metabolic imbalances.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThe test includes assessment of mitochondrial function, oxidative stress, detoxification, neurotransmitter metabolism and dysbiosis-related metabolites. Add-on options for fatty acids, urine elements and vitamin D can further expand the profile to include essential fats, minerals and nutrient co-factors.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eChanges in organic acid, amino acid and fatty acid patterns have been observed in contexts such as fatigue, mood variation, metabolic dysfunction and cardiometabolic risk. Metabolomix+ offers a convenient non-invasive way to explore how nutritional status and lifestyle factors may influence these biochemical pathways and supports a personalised approach to nutritional planning.\u003c\/p\u003e\n\u003cspan id=\"ctl00_cphBody_lblServingdetails\"\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"col-md-4\"\u003e\n\u003cdiv class=\"box box-primary\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 0.875rem;\"\u003eDosage--\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eSample required\u003c\/strong\u003e:\u003c\/span\u003e\u003cbr\u003e\u003cspan\u003eUrine - FMV\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eAvailable add-ons:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eFatty acids add-on for Metabolomix+\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eUrine elements add-on for Metabolomix+\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eVitamin D add-on for Metabolomix+\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eResearch--\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003eKaluzna-Czaplinska J. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. \u003cem\u003eClin Biochem.\u003c\/em\u003e 2011;44(8-9):686-691.\u003c\/li\u003e\n\u003cli\u003eBroquist HP, Luhby AL. Detection and isolation of formiminoglutamic acid from urine in folic acid deficiency in humans. \u003cem\u003eProc Soc Exp Biol Med.\u003c\/em\u003e 1959;100(2):349-354.\u003c\/li\u003e\n\u003cli\u003eSun A-l, Ni Y-h, Li X-b, et al. Urinary methylmalonic acid as an indicator of early vitamin B12 deficiency and its role in polyneuropathy in type 2 diabetes. \u003cem\u003eJ Diab Res.\u003c\/em\u003e 2014;2014.\u003c\/li\u003e\n\u003cli\u003eKwok T, Cheng G, Lai W, Poon P, Woo J, Pang C. Use of fasting urinary methylmalonic acid to screen for metabolic vitamin B12 deficiency in older persons. \u003cem\u003eNutrition.\u003c\/em\u003e 2004;20(9):764-768.\u003c\/li\u003e\n\u003cli\u003eBrown R, Thornton MJ, Price J. The effect of vitamin supplementation on the urinary excretion of tryptophan metabolites by pregnant women. \u003cem\u003eJ Clin Invest.\u003c\/em\u003e 1961;40(4):617-623.\u003c\/li\u003e\n\u003cli\u003eLykouras L, Markianos M, Hatzimanolis J, Malliaras D, Stefanis C. Association of biogenic amine metabolites with symptomatology in delusional (psychotic) and nondelusional depressed patients. \u003cem\u003eProg Neuro-Psychopharmacol Biol Psych.\u003c\/em\u003e 1995;19(5):877-887.\u003c\/li\u003e\n\u003cli\u003eFrankenhaeuser M, Lundberg U, Von Wright MR, Von Wright J, Sedvall G. Urinary monoamine metabolites as indices of mental stress in healthy males and females. \u003cem\u003ePharmacol Biochem Behav.\u003c\/em\u003e 1986;24(6):1521-1525.\u003c\/li\u003e\n\u003cli\u003eMitochondrial Medicine Society's Committee on D, Haas RH, Parikh S, et al. The in-depth evaluation of suspected mitochondrial disease. \u003cem\u003eMol Genet Metab.\u003c\/em\u003e 2008;94(1):16-37.\u003c\/li\u003e\n\u003cli\u003eDimmock DP, Lawlor MW. Presentation and Diagnostic Evaluation of Mitochondrial Disease. \u003cem\u003ePediatr Clin North Am.\u003c\/em\u003e 2017;64(1):161-171.\u003c\/li\u003e\n\u003cli\u003eWu H, Jiang K, Gu G, Wu Y, Yu S. [The relationship of occupational stress and the level of some hormone metabolites in urine]. \u003cem\u003eChin J Indust Hyg Occup Dis.\u003c\/em\u003e 2014;32(2):83-86.\u003c\/li\u003e\n\u003cli\u003eJeon SW, Kim Y-K. Inflammation-induced depression: Its pathophysiology and therapeutic implications. \u003cem\u003eJ Neuroimmunol.\u003c\/em\u003e 2017;313:92-98.\u003c\/li\u003e\n\u003cli\u003eRao TSS, Asha MR, Ramesh BN, Rao KSJ. Understanding nutrition, depression and mental illnesses. \u003cem\u003eIndian J Psychiatry.\u003c\/em\u003e 2008;50(2):77-82.\u003c\/li\u003e\n\u003cli\u003eO'Connell BS. Select vitamins and minerals in the management of diabetes. \u003cem\u003eDiabetes Spectr.\u003c\/em\u003e 2001;14(3):133-148.\u003c\/li\u003e\n\u003cli\u003eHarris WS. Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. \u003cem\u003ePharmacol Res.\u003c\/em\u003e 2007;55(3):217-223.\u003c\/li\u003e\n\u003cli\u003eSpencer SJ, Korosi A, Layé S, Shukitt-Hale B, Barrientos RM. Food for thought: how nutrition impacts cognition and emotion. \u003cem\u003eSci Food.\u003c\/em\u003e\u003cspan\u003e \u003c\/span\u003e2017;1(1):1-8.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Nordic Laboratories","offers":[{"title":"Default Title","offer_id":48624504373403,"sku":"TK-METABOL","price":49305.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/TK-METABOL.webp?v=1781284096"},{"product_id":"amino-acids-urine-fmv-g-x-1-test-kit","title":"Amino Acids Urine (FMV) (G) X 1 Test Kit","description":"\u003cp\u003eDescription--\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eProtein intake concerns:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eassessing adequacy of dietary protein.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigestion issues:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eexploring protein breakdown or utilisation challenges.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWeight-related concerns:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eappetite regulation, metabolic balance or dietary guidance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMood changes:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003elow mood, irritability or reduced emotional resilience.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFatigue:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003elow stamina possibly related to amino acid imbalance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMuscle concerns:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ereduced recovery, weakness or low muscle tone.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNutrient cofactor concerns:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eevaluating possible vitamin or mineral insufficiencies affecting amino acid pathways.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAppetite changes:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efluctuations in hunger linked to protein intake.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStress-related symptoms:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eincreased demand for amino acids during chronic stress.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRestrictive diets:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003evegan, low-protein or medically-limited diets requiring assessment.\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLabel--\u003c\/p\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv id=\"tab_2\" class=\"tab-pane active\"\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv class=\"tab-pane active\" id=\"tab_2\"\u003e\n\u003cp\u003eThe Amino Acids Urine (FMV) test measures nutritionally essential amino acids, non-essential amino acids, intermediary metabolites and dietary peptide-related markers from a preserved first-morning urine sample. This provides insight into protein intake, digestion, absorption and metabolic processing. The profile also reflects how amino acids are being utilised within pathways that rely on specific micronutrient cofactors.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThis assessment may relate to concerns involving dietary protein adequacy, digestion and absorption patterns, mood changes, fatigue, muscle weakness, weight management, nutrient insufficiencies or the metabolic demands associated with stress. It may also be useful when evaluating dietary patterns such as vegan or low-protein diets.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003ePractitioners typically interpret the findings alongside dietary habits, digestive symptoms, lifestyle factors, stress exposure, supplement use, activity levels and information shared by clients. This supports a clearer understanding of how amino acid patterns may align with reported symptoms.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cspan id=\"ctl00_cphBody_lblServingdetails\"\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 0.875rem;\"\u003eDosage--\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eSpecimen\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eUrine- First morning void-preserved with sulfosalicylic acid\u003cbr\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eContainer\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003e1x clear-capped vial\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e1x green-capped vial\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003ePatient preparation\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eFluid intake should be limited to six 8-ounce glasses of fluid\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong style=\"font-size: 0.875rem;\"\u003eClick to Download :\u003c\/strong\u003e\u003c\/p\u003e\n\u003cstyle type=\"text\/css\"\u003e\n        td {border: 1px solid #cccccc;}\n        br {mso-data-placement: same-cell;}\n        .bold {font-weight: bold;}\n    \u003c\/style\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/Amino_Acids_-_Collection_Instructions_-_NL.Amino_Acids_Analysis_FMV_test_instructions-GB-04_2559.pdf?v=1779444259\" target=\"_blank\" rel=\"noopener\"\u003eCollection instructions - English\u003c\/a\u003e\u003cbr\u003e\u003ca href=\"https:\/\/dnalifevms.com\/ProductPDF\/Intestinal-Permeability-Interp-Guidepdf_2537.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003c\/a\u003e\u003ca href=\"https:\/\/dnalifevms.com\/ProductPDF\/IPAGenova-updated0312pdf_2537.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003c\/a\u003e\n\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/amino-acids-Sample_Report_-_urine-3500-sample-report_2pdf_2559.pdf?v=1779444260\" target=\"_blank\" rel=\"noopener\"\u003e\u003cspan style=\"font-size: 0.875rem;\"\u003eSample Report - English\u003c\/span\u003e\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eResearch--\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e","brand":"Nordic Laboratories","offers":[{"title":"Default Title","offer_id":48624625909915,"sku":"TK-METABOL","price":99999.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/Test-Metabolomix.jpg?v=1779434104"},{"product_id":"gi-map-x-1-test-kit","title":"GI MAP X 1 Test Kit","description":"\u003cp\u003eDescription--\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigestive symptoms:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eChronic diarrhoea, constipation, bloating, gas or abdominal pain.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAltered bowel habits:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eOngoing changes in stool frequency, urgency or consistency.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSuspected gastrointestinal disorders:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eEvaluation in contexts such as irritable bowel syndrome, inflammatory bowel disease or coeliac disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecurrent gastrointestinal symptoms:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eExploration of potential bacterial contributors including Escherichia coli or Helicobacter pylori.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMalabsorption concerns:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eUnexplained weight loss, anaemia or signs of nutrient insufficiency.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eImmune-related conditions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eInvestigation of gastrointestinal factors in autoimmune or inflammatory presentations.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSkin conditions:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eEczema, acne or psoriasis where gut involvement is considered.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFatigue or neurological symptoms:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eBrain fog, low energy or mood changes in complex clinical presentations.\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLabel--\u003c\/p\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv id=\"tab_2\" class=\"tab-pane active\"\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv class=\"tab-pane active\" id=\"tab_2\"\u003e\n\u003cp\u003eThe Gastrointestinal Microbial Assay Plus (GI-MAP) is an innovative clinical tool that measures gastrointestinal microbiota DNA from a single stool sample using quantitative polymerase chain reaction (qPCR) technology.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThe panel provides insight into microbial balance and potential contributors to gastrointestinal dysfunction. It assesses a wide range of organisms that may influence gut health, including pathogenic bacteria, commensal bacteria, opportunistic organisms, fungi, viruses and parasites, together with key intestinal and immune markers such as calprotectin, secretory IgA and pancreatic elastase. This comprehensive analysis helps practitioners understand how microbial patterns may relate to digestive symptoms or broader health presentations.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eResults are interpreted alongside clinical history, digestive function and environmental factors. Quantitative reporting allows comparison over time to help review changes in microbial patterns following dietary, lifestyle or therapeutic interventions. Add-ons available include zonulin, StoolOMX (bile acids and short-chain fatty acids) and gluten peptide.\u003c\/p\u003e\n\u003cspan id=\"ctl00_cphBody_lblServingdetails\"\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 0.875rem;\"\u003eDosage--\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eSpecimen\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eStool sample \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eContainer\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003e1x orange-capped stool vial\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003ePatient preparation\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003ePlease refrain from taking aspirin for two days prior to collecting your sample.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eNever discontinue prescription medication without first consulting your physician.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003e\u003cspan\u003eAge requirements\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003eCan be used on all ages. However, often the microbiome of infants will appear very “dysbiotic”, as the microbiome and the infant’s immune system is very immature.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eAvailable add-ons:\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e• Zonulin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMedications\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWe recommend continuing all prescription medications prior to testing. Please carefully document any relevant recent or current medication use. Medications that may alter the composition of the microbiome include:\u003c\/p\u003e\n\u003cul type=\"disc\"\u003e\n\u003cli\u003eAntibiotics -(after finishing Antibiotics, wait 4-6 weeksbefore collecting sample)\u003c\/li\u003e\n\u003cli\u003eImmune Suppressants\/ Oral steroids- will likely cause a lower Secretory IgA, Anti-gliadin, and calprotectin result (after finishing these meds, wait 4-6 weeks before collecting sample)\u003cbr\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eGastroenterology Procedures:\u003cbr\u003e\u003c\/strong\u003eWait at least 4 weeks from colonoscopy or barium enema before beginning the test.\u003c\/p\u003e\n\u003cp data-empty=\"true\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eSupplements:\u003c\/strong\u003e\u003cbr\u003eIt is not necessary to discontinue most supplements before testing.  It is the provider’s discretion to recommend discontinuing supplements.  Many providers will want to understand the impact of supplements on the gut ecosystem and will want their patients to continue supplements during testing.  If a provider wants more of a “baseline” assessment using the GI-MAP, they may recommend discontinuing supplements prior to testing. There are a few categories of supplements that deserve consideration:\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eNon-prescription anti-microbial agents:\u003c\/strong\u003e\u003cbr\u003eWhile we don’t require that people discontinue antibiotics or antimicrobial substances before collection their stool sample, doing the test while taking these substances can influence the test results.  If possible, we recommend discontinuing anti-microbial agents 4-6 weeks before testing.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eEnzymes:\u003c\/strong\u003e\u003cbr\u003eOral enzyme use will not change the elastase-1 finding. If the enzyme contains lipase or ox bile, it may decrease the value for steatocrit.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eOx Bile\/Lipase:\u003c\/strong\u003e\u003cbr\u003eOx bile\/lipase intake will affect the steatocrit level but will not affect Elastase-1. If you would like to see your patient’s baseline without supplementation, discontinue at least 3 days before testing. If you would like to see how well-managed your patient is on their supplement, do not discontinue.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eProbiotics:\u003c\/strong\u003e\u003cbr\u003eProbiotic supplements can influence the normal and opportunistic bacteria flora. If you would like to assess your patient’s baseline microbial balance without supplementation, discontinue for ~2 weeks prior to testing. If you would like to see the influence of the current probiotic supplement, do not discontinue prior to testing.  \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eBiofilm disruptors:\u003c\/strong\u003e\u003cbr\u003eThere is no published evidence to suggest that a biofilm disruptor will improve detection of organisms. However, some clinicians choose to use a biofilm disruptor with their patients up to 14 days before testing. This is an option but not a requirement for testing.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eResearch--\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eAbubakar I, Irvine L, Aldus CF, et al. A systematic review of the clinical, public health and costeffectiveness of rapid diagnostic tests for the detection and identification of bacterial intestinal pathogens in faeces and food. Health Technol Assess. 2007;11(36):1-216.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eAmar CF, East CL, Gray J, Iturriza-Gomara M, Maclure EA, McLauchlin J. Detection by PCR of Eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English casecontrol Infectious Intestinal Disease Study (1993-1996). Eur J Clin Microbiol Infect Dis. 2007;26(5):311-323.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eBischoff SC, Barbara G, Buurman W, et al. Intestinal permeability — a new target for disease prevention and therapy. BMC gastroenterology. 2014;14:189.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eCanny GO, McCormick BA. Bacteria in the intestine, helpful residents or enemies from within? Infection and immunity. 2008;76(8):3360-3373.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eFasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nature clinical practice. 2005;2(9):416-422.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eIijima Y, Asako NT, Aihara M, Hayashi K. Improvement in the detection rate of diarrhoeagenic Bacteria in human stool specimens by a rapid real-time PCR assay. Journal of medical microbiology. 2004;53(Pt 7):617-622.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e Kahlau P, Malecki M, Schildgen V, et al. Utility of two novel multiplexing assays for the detection of gastrointestinal pathogens - a first experience. SpringerPlus. 2013;2(1):106.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eKamada N, Seo SU, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nature reviews. Immunology. 2013;13(5):321-335.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eKhanna S, Tosh PK. A clinician's primer on the role of the microbiome in human health and disease. Mayo Clinic proceedings. 2014;89(1):107-114.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eOthman M, Aguero R, Lin HC. Alterations in intestinal microbial flora and human disease. Current opinion in gastroenterology. 2008;24(1):11-16.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e Rashid T, Ebringer A. Autoimmunity in Rheumatic Diseases Is Induced by Microbial Infections via Crossreactivity or Molecular Mimicry. Autoimmune diseases. 2012;2012:539282. \u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSchabereiter-Gurtner C, Hirschl AM, Dragosics B, et al. Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. Journal of clinical microbiology. 2004;42(10):4512-4518.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eStecher B, Hardt WD. The role of microbiota in infectious disease.Trends in microbiology. 2008;16(3):107-114.\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003e Tiwana H, Wilson C, Walmsley RS, et al. Antibody responses to gut bacteria in ankylosing spondylitis, rheumatoid arthritis, Crohn's disease and ulcerative colitis. Rheumatology international. 1997;17(1):11-16.\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Nordic Laboratories","offers":[{"title":"Default Title","offer_id":48632472895643,"sku":"TK-GI-MAP","price":99999.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/Test-Gi_Map-without-Heading.jpg?v=1781018399"},{"product_id":"gi360-essentials-x1-day-microbiome-parasites-basics-only-x-1-test-kit","title":"GI360 Essentials x1 day (Microbiome, parasites \u0026 basics only) x 1 Test Kit","description":"\u003cp\u003eDescription--\u003cspan style=\"color: rgb(0, 0, 0);\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eDigestive discomfort:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ebloating, gas, abdominal pain or irregular bowel habits.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eChronic or acute diarrhoea:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eloose stools, urgency or diarrhoea following illness or travel.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eIBS or IBD:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eongoing digestive symptoms where microbiome patterns may be relevant.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFood sensitivities:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003edigestive or systemic reactions suspected to relate to microbial imbalance.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eUnexplained fatigue:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003etiredness potentially linked with gut-related factors under review.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eJoint discomfort:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eintermittent stiffness or pain sometimes observed alongside gut symptoms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eRecurrent infections:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eindividuals with frequent immune challenges where gut health is being explored.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNutritional deficiencies:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003esuboptimal nutrient status possibly associated with malabsorption patterns.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMucosal barrier concerns:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003epractitioners assessing potential disruption of gut lining integrity.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFever, nausea or vomiting of unclear origin:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ewhen gastrointestinal pathogens are a consideration.\u003cbr\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eLabel--\u003c\/p\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv id=\"tab_2\" class=\"tab-pane active\"\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv class=\"tab-pane active\" id=\"tab_2\"\u003e\n\u003cdiv class=\"col-md-8\"\u003e\n\u003cdiv class=\"nav-tabs-custom tabcustomeblue-theamtab\"\u003e\n\u003cdiv class=\"tab-content tabcustomeblue-theam\"\u003e\n\u003cdiv class=\"tab-pane active\" id=\"tab_2\"\u003e\n\u003cp\u003eThe GI360 Essentials (1-day) test combines multiplex PCR, culture, MALDI-TOF identification, microscopy and biochemical assays to evaluate a single stool sample for pathogenic organisms, parasites, viral targets and core microbiome indicators. The profile includes analysis of microbial abundance and diversity across key bacterial phyla.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003eThis assessment may be clinically useful when exploring persistent digestive concerns, suspected infections, microbiome imbalance or digestive symptoms that appear to relate to microbial factors. Although a single-day sample provides a snapshot rather than a multi-day view, it still offers detailed insight into microbial composition, dysbiosis patterns and potential pathogenic organisms.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003ePractitioners typically interpret GI360 Essentials findings alongside clinical history, diet, symptom patterns and lifestyle influences. When used in this way, the test can support discussions about gut ecology, digestive function, potential triggers and practical next steps.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cspan id=\"ctl00_cphBody_lblServingdetails\"\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cspan id=\"ctl00_cphBody_lblServingdetails\"\u003e\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cspan style=\"font-size: 0.875rem;\"\u003eDosage--\u003c\/span\u003e\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cstrong\u003e\u003cspan lang=\"EN-US\"\u003eSpecimen requirements:\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan lang=\"EN-US\"\u003eStool\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan lang=\"EN-US\"\u003e1 day collection \u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cstrong\u003e\u003cu\u003eNo Call \/ Inhibited\u003c\/u\u003e\u003cbr\u003e\u003c\/strong\u003eIn certain circumstances, stool samples may not yield results for a limited section of viruses, pathogenic bacteria and parasites [known as : No Call \/ Inhibited]. Statistically this can affect approximately 6% of tests.\u003cbr\u003eMany factors contribute to this issue including diet, medication, supplements, and competing DNA. Excessive calcium, tannic acid, bile salts, haemoglobin, melanin, collagen, urea, degradation products, complex polysaccharides and polyphenolic substances have also been found to cause inhibition.Test reports affected are not considered to be defective and thus are not eligible for cancellation or refunds.\u003cbr\u003eResubmission of the a supplementary sample to attempt analysis can be accommodated with billable costs limited to supply and return shipping.\u003cbr\u003eBy ordering this test, you accept the conditions and risks explained here.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003eAlso available as 2 and 3 day collection.\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cstrong\u003e\u003cspan lang=\"EN-US\"\u003eAverage processing time:\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan lang=\"EN-US\"\u003e21 days\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cstrong\u003e\u003cspan lang=\"EN-US\"\u003eAvailable add-ons:\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003cspan lang=\"EN-US\"\u003eZonulin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eAge Considerations:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe PCR Microbiome section (only) may best be served for those ages 2 and above due to variations in the microbiome in ages 0-2.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eResearch--\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• Aasbrenn M, Valeur J, Farup PG. Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity. Scandinavian Journal of Clinical and Laboratory Investigation. 2017;78(1-2):109-113. DOI: 10.1080\/00365513.2017.1419372\u003cbr\u003e\u003cbr\u003e• Andréasson K, Alrawi Z, Persson A, Jönsson G, Marsal J. Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease. Arthritis Research \u0026amp; Therapy. 2016;18(1). DOI: 10.1186\/s13075-016-1182-z\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e• Bennet SMP, Böhn L, Störsrud S, et al. Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut. 2017;67(5):872-881. DOI: 10.1136\/gutjnl-2016-313128\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e• Casén C, Vebø HC, Sekelja M, et al. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD. Alimentary Pharmacology \u0026amp; Therapeutics. 2015;42(1):71-83. DOI: 10.1111\/apt.13236\u003cbr\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e• Farup PG, Aasbrenn M, Valeur J. Separating “good” from “bad” faecal dysbiosis – evidence from two cross-sectional studies. BMC Obesity. 2018;5(1). DOI: 10.1186\/s40608-018-0207-3\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e• Farup P, Valeur J. Faecal Microbial Markers and Psychobiological Disorders in Subjects with Morbid Obesity. A Cross-Sectional Study. Behavioral Sciences. 2018;8(10):89. DOI: 10.3390\/bs8100089\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e• Magnusson MK, Strid H, Sapnara M, et al. Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition. Journal of Crohns and Colitis. 2016;10(8):943-952. DOI: 10.1093\/ecco-jcc\/jjw051\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e• Magnusson MK, Strid H, Isaksson S, Simrén M, Öhman L. The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis. Inflammatory Bowel Diseases. 2017;23(6):956-966. DOI: 10.1097\/mib.0000000000001130\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e• Mazzawi T, Lied GA, Sangnes DA, et al. The kinetics of gut microbial community composition in patients with irritable bowel syndrome following fecal microbiota transplantation. Plos One. 2018;13(11). DOI: 10.1371\/journal.pone.0194904\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e• Olbjørn C, Småstuen MC, Thiis-Evensen E, et al. Fecal microbiota profiles in treatment-naïve pediatric inflammatory bowel disease – associations with disease phenotype, treatment, and outcome. Clinical and Experimental Gastroenterology. 2019;Volume 12:37-49. DOI: 10.2147\/ceg.s186235\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e• Thorkildsen LT, Nwosu FC, Avershina E, et al. Dominant Fecal Microbiota in Newly Diagnosed Untreated Inflammatory Bowel Disease Patients. Gastroenterology Research and Practice. 2013;2013:1-13. DOI: 10.1155\/2013\/636785\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e• Valeur J, Småstuen MC, Knudsen T, Lied GA, Røseth AG. Exploring Gut Microbiota Composition as an Indicator of Clinical Response to Dietary FODMAP Restriction in Patients with Irritable Bowel Syndrome. Digestive Diseases and Sciences. 2018;63(2):429-436. DOI: 10.1007\/s10620-017-4893-3\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e• Vebø HC, Sekelja M, Nestestog R, et al. Temporal Development of the Infant Gut Microbiota in Immunoglobulin E-Sensitized and Nonsensitized Children Determined by the GA-Map Infant Array. Clinical and Vaccine Immunology. 2011;18(8):1326-1335. DOI: 10.1128\/cvi.00062-11\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cspan\u003e• Vebø HC, Karlsson MK, Avershina E, Finnby L, Rudi K. Bead-beating artefacts in the Bacteroidetes to Firmicutes ratio of the human stool metagenome. Journal of Microbiological Methods. 2016;129:78-80. DOI: 10.1016\/j.mimet.2016.08.005\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cstyle type=\"text\/css\"\u003e\n        td {border: 1px solid #cccccc;}\n        br {mso-data-placement: same-cell;}\n        .bold {font-weight: bold;}\n    \u003c\/style\u003e","brand":"Nordic Laboratories","offers":[{"title":"Default Title","offer_id":48752003088539,"sku":"TK-GI360-E","price":39805.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0613\/3694\/4795\/files\/TK-GI360-E.webp?v=1781285426"}],"url":"https:\/\/fmihealth.com\/collections\/test-kit.oembed","provider":"FMI health","version":"1.0","type":"link"}